UT-MD Anderson Cancer Center: Vaccine Demonstrates Potential in Delaying Relapse of KRAS-Mutated Pancreatic and Colorectal Cancers
January 10, 2024
January 10, 2024
HOUSTON, Texas, Jan. 10 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Jan. 9, 2024:
* * *
All patients receiving highest dose had significant T cell responses that correlated with significant reduction in risk of relapse
* * *
A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phas . . .
* * *
All patients receiving highest dose had significant T cell responses that correlated with significant reduction in risk of relapse
* * *
A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phas . . .